Pure Global
NCT04292639

Vital USA Respiratory Rate Validation In Adults

Final Test Report for Vital USA Respiratory Rate Validation In Adults
Vital USA, Inc.·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Respiratory Complication
Drug/Device/Intervention
The Vital Detect Pulse Oximeter
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Vital USA, Inc.
Location
Louisville, United States of America
Timeline & enrollment
Phase
N/A
Start date
Dec 17, 2019
End date
Dec 20, 2019
Enrollment
20 participants
Primary outcome

Respiratory Rate Accuracy Validation for the Vital USA Vital Detect Monitor.

Summary

Vital USA is dedicated to developing and applying innovative electronic medical solutions
 that improve patient care in multiple clinical settings. Vital USA is a manufacturer of a
 multi-parameter patient monitor that is intended to be used in a variety of medical settings
 including hospitals, medical offices and patients' homes.

ICD-10 classifications
Respiratory disorder, unspecifiedOther respiratory disordersRespiratory failure, unspecifiedOther postprocedural respiratory disordersOther specified respiratory disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04292639
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT04292639 through Pure Global AI's free database. This phase not specified trial is sponsored by Vital USA, Inc. and is currently Completed. The study focuses on Respiratory Complication. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.